TippingPoint Biosciences
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer
$4.5MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer